Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
769.50    4.50 (0.59%)
Bid:
770.00
Ask:
772.50
Spread: 2.50 (0.325%)
Market Cap: £886.26m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Trading Update

12 Apr 2017 07:00

RNS Number : 2464C
Kainos Group plc
12 April 2017
Β 

12 April 2017

Β 

Kainos Group plc

Β 

("Kainos" or "the Company")

Β 

Trading Update

Β 

Kainos Group plc, a leading provider of Digital Services and Platforms, today issues a trading update for the year ended 31 March 2017.

Β 

Trading in the year ended 31 March 2017 has continued to be in line with market expectations; the Company has experienced good growth across all divisions, and remains well positioned in its core markets.

Β 

The increasing trends towards digitisation and adoption of enterprise Software as a Service (SaaS) solutions have continued to generate strong demand for the Company's Digital Services in both public and commercial markets in the UK and Europe.

Β 

Growth in Digital Platforms remains solid, supported by sustained momentum of Kainos WorkSmart contract wins, although limited funding in the UK's NHS continues to moderate short term growth of Kainos Evolve platforms. The Company continues to invest in development, sales and marketing of its Evolve Integrated Care platform.

Β 

Kainos has a robust balance sheet with no debt and strong cash generation. The business has a solid pipeline, which includes a growing level of recurring revenue. Recruitment remains strong, with over 216 people joining Kainos since 1 April 2016, bringing the total number of employees and contractors worldwide to 975 at the end of March 2017.

Β 

The announcement of Kainos results for the year ended 31Β March 2017 will be made on Tuesday 30Β May 2017.

Β 

- ENDS -

Β 

For further information, please contact:

Β 

Kainos via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

Brian Gannon, SVP Corporate Development

Β 

Investec Bank plc +44Β 20 7597 5970

Patrick Robb / Dominic Emery

Β 

Canaccord Genuity +44 20 7523 4606

Simon Bridges / Emma Gabriel

Β 

FTI Consulting LLP +44 20 3727 1000

Matt Dixon / Nicola Krafft

Β 

About Kainos

Kainos Group plc is a UK-based provider of Digital Services and Digital Platforms.

The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the largest boutique partner for Workday Inc. ('Workday') in Europe, responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise customers.

The Group's Digital Platforms comprise specialised digital products in the mobile healthcare and automated testing arenas. Evolve Electronic Medical Records ('EMR') is the market leading product for the digitisation of patient notes in the Acute sector of the NHS; Evolve Integrated Care ('IC') is a SaaS-based integrated care platform for the NHS and international healthcare providers; and Smart is an automated testing platform for Workday customers.

Kainos employs approximately 1,000 staff and contractors across eight offices in Europe and the USA, working interchangeably across its Services and Platforms businesses.

Kainos is listed on the London Stock Exchange (KNOS). For further information, please visit www.kainos.com.

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTIBMFTMBMBBJR
Date   Source Headline
18th Nov 20247:00 amRNSTransaction in Own Shares
15th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 202412:32 pmRNSDirector / PDMR shareholdings
11th Nov 20247:01 amRNSShare buyback programme
11th Nov 20247:00 amRNSInterim Results
31st Oct 20247:00 amRNSTrading Update
1st Oct 20249:49 amRNSTotal Voting Rights
24th Sep 20241:11 pmRNSBoard Changes
24th Sep 20241:06 pmRNSResults of Annual General Meeting
9th Sep 202410:14 amRNSHolding(s) in Company
2nd Sep 202411:13 amRNSTotal Voting Rights
2nd Sep 20247:00 amRNSTrading Statement
15th Aug 202410:00 amRNSNotice of AGM
1st Aug 202410:34 amRNSTotal Voting Rights
31st Jul 20244:41 pmRNSAnnual Report 2024
25th Jul 20242:30 pmRNSWorkday Partnership & Co-Sell drives £200m Target
11th Jul 202410:26 amRNSTR-1: Notification of major holdings
2nd Jul 20249:57 amRNSDirector / PDMR shareholdings
1st Jul 20249:23 amRNSTotal Voting Rights
3rd Jun 20243:53 pmRNSDirector/PDMR Shareholding
3rd Jun 202410:36 amRNSTotal Voting Rights
20th May 20247:01 amRNSBoard and Board Committee Changes
20th May 20247:00 amRNSFull year results
1st May 202412:00 pmRNSTotal Voting Rights
15th Apr 20247:00 amRNSYear-end Trading Update
11th Apr 20243:50 pmRNSHolding(s) in Company
2nd Apr 202412:12 pmRNSTotal Voting Rights
15th Mar 20241:48 pmRNSHolding(s) in Company
28th Feb 20243:16 pmRNSHolding(s) in Company
5th Feb 202412:51 pmRNSHolding(s) in Company
1st Feb 20244:29 pmRNSHolding(s) in Company
1st Feb 20244:21 pmRNSHolding(s) in Company
1st Feb 202412:13 pmRNSTotal Voting Rights
31st Jan 20244:09 pmRNSDirector/PDMR Shareholding
2nd Jan 202412:15 pmRNSTotal Voting Rights
22nd Dec 20239:21 amRNSExecutive Director PSP Award/PDMR shareholdings
1st Dec 20239:35 amRNSTotal Voting Rights
17th Nov 202311:13 amRNSExecutive Director PSP Award/PDMR shareholdings
13th Nov 20237:00 amRNSInterim Results
1st Nov 202310:48 amRNSTotal Voting Rights
2nd Oct 202312:41 pmRNSTotal Voting Rights
2nd Oct 20237:00 amRNSConfirmation of Board Changes
27th Sep 20235:52 pmRNSDirector/PDMR Shareholding
21st Sep 20232:54 pmRNSResults of Annual General Meeting
21st Sep 202311:59 amRNSConfirmation of CEO appointment
1st Sep 202312:34 pmRNSTotal Voting Rights
31st Aug 20237:00 amRNSTrading Update
10th Aug 20232:48 pmRNSNotice of AGM
3rd Aug 202310:41 amRNSMount Charles & Bankmore Square, Belfast

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.